These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5420803)

  • 1. Pseudolymphoma induced by diphenylhydantoin.
    Choovivathanavanich P; Wallace EM; Scaglione PR
    J Pediatr; 1970 Apr; 76(4):621-3. PubMed ID: 5420803
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudolymphoma induced by diphenylhydantoin.
    Gams RA
    J Pediatr; 1970 Dec; 77(6):1100-1. PubMed ID: 5486632
    [No Abstract]   [Full Text] [Related]  

  • 3. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)].
    Matsuo T; Matsumoto A; Miyasaki K
    Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 6. Localized cutaneous pseudolymphoma associated with phenytoin therapy: a case report.
    Adams JD
    Australas J Dermatol; 1981 Apr; 22(1):28-9. PubMed ID: 7259668
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature.
    Harris DW; Ostlere L; Buckley C; Whittaker S; Sweny P; Rustin MH
    Br J Dermatol; 1992 Oct; 127(4):403-6. PubMed ID: 1419762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin-induced pseudolymphoma: reevaluation using modern molecular biology techniques.
    Jeng YM; Tien HF; Su IJ
    Epilepsia; 1996 Jan; 37(1):104-7. PubMed ID: 8603615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin-induced pseudolymphoma with mycosis fungoides manifestations.
    Cooke LE; Hardin TC; Hendrickson DJ
    Clin Pharm; 1988 Feb; 7(2):153-7. PubMed ID: 3349752
    [No Abstract]   [Full Text] [Related]  

  • 10. [Macrocytic anemia due to folic acid deficiency and non-Hodgkin's lymphoma associated with prolonged diphenylhydantoin ingestion].
    Pereira A; Cervantes F; Rozman C
    Med Clin (Barc); 1985 Oct; 85(12):503-5. PubMed ID: 4079508
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).
    Lapes MJ; Vivacqua RJ; Antoniades K
    Lancet; 1976 Jan; 1(7952):198. PubMed ID: 54713
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenytoin-induced pseudolymphoma syndrome: an immunologic study.
    Charlesworth EN
    Arch Dermatol; 1977 Apr; 113(4):477-80. PubMed ID: 848977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant lymphoma after diphenylhydantoin (dilantin) therapy.
    Li FP; Willard DR; Goodman R; Vawter G
    Cancer; 1975 Oct; 36(4):1359-62. PubMed ID: 1175133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant-induced lymphoma.
    Fried MP; Sunwoo Y
    Laryngoscope; 1975 Oct; 85(10):1770-81. PubMed ID: 1186408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual dual hypersensitivity reaction induced by diphenylhydantoin.
    Sisca TS
    Am J Hosp Pharm; 1973 May; 30(5):446-9. PubMed ID: 4267436
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of primary B-cell origin lymphoma of the stomach seen during diphenylhydantoin therapy (author's transl)].
    Matoba K; Katsumata T; Kakei M; Kuwata H; Nakazawa H; Saigeni K; Okabe H; Chin S; Maekawa K; Katsuoka K; Oh-Ida M; Atari H
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1797-802. PubMed ID: 6976466
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.
    Isobe T; Tomita M; Matsumoto J; Itoh T; Fujita T
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):1-5. PubMed ID: 6858559
    [No Abstract]   [Full Text] [Related]  

  • 18. Diphenylhydantoin induced granulocytopenia following a seizure prophylaxis after a depressed skull fracture.
    Gabl M; Kostron H
    Zentralbl Neurochir; 1986; 47(4):339-41. PubMed ID: 3105193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation.
    Rosenthal CJ; Noguera CA; Coppola A; Kapelner SN
    Cancer; 1982 Jun; 49(11):2305-14. PubMed ID: 6978761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is phenytoin carcinogenic?
    Lancet; 1971 Nov; 2(7733):1071-2. PubMed ID: 4106919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.